Statement Of Investor Complaints For The Quarter Ended 31St December, 2017
Pursuant to the provisions of Regulation 13(3) (Listing Obligation and Disclosure Requirement) Regulations, 2015, enclosed herewith is the Investor Grievance Report of our company for the Quarter ended 31st December, 2017. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajkamal Sukhani & Shweta Govardhan Dhoot Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Govardhan M Dhoot, Brijmohan M Dhoot & Smt. Rajkamal Sukhani Clarification
With reference to increase in Volume, Mangalam Drugs & Organics Ltd has submitted to BSE a copy of Clarification is enclosed. Clarification sought from Mangalam Drugs & Organics Ltd
The Exchange has sought clarification from Mangalam Drugs & Organics Ltd on December 28, 2017, with reference to increase in Volume.The reply is awaited. Broker's Call: Mangalam Drugs (Buy)
Sunidhi ResearchMangalam Drugs (Buy)CMP: 186.35Target: 325Mangalam Drugs & Organics (MDOL) was incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd.... Fixes Revised Record Date For The Interim Dividend
This is to inform that you that Company has fixed the Record Date as 22nd December, 2017 for the purpose of eligibility for payment of Interim Dividend. Outcome of Board Meeting
Revised Letter for outcome of Board Meeting dated 12th December, 2017. Fixes Record Date For Interim Dividend
Pursuant to the provisions of Regulation 42 of the Listing Regulations, the Company has fixed the Record date of December 20, 2017 for ascertainment of the shareholders entitled to receive the aforesaid Interim Dividend. Board declares Interim Dividend
Mangalam Drugs & Organics Ltd has informed BSE that the Board of Directors of the Company at their meeting held on December 12, 2017 has declared an interim dividend of 50 paise (Fifty paise only) per equity share having face value of Rs. 10/- each (i.e. 5%) on the equity shares of the Company for the financial year 2017-18.